ワクチンを１００日で提供するためのサイエンス

抄録

In order to eliminate the bottleneck of non-clinical studies in infectious disease vaccine development research in Japan and to realize the 100-day mission, this study will bring together researchers in infectious disease vaccine research at Japan's top research institutions, the Institute of Medical Science of the University of Tokyo, the National Institute of Infectious Diseases, and the National Institute of Biomedical Innovation and Nutrition, to conduct GLP studies in small animals to primates, and to develop a new vaccine for infectious diseases. The three research institutes will collaborate with CROs capable of conducting GLP studies on small animals to primates, and under appropriate BSL management, will establish a research system that enables exploratory research and efficacy verification experiments for regulatory approval applications on novel coronaviruses, influenza viruses, and other unknown infectious pathogens, and will also develop a research system that will enable the development of young researchers. Promote seamless and borderless team building, including the development of young researchers.

Lab HP; https://vaccine-science.ims.u-tokyo.ac.jp/en/message/

U Tokyo Crowdfunding；https://utf.u-tokyo.ac.jp/project/pjt142